Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 356

1.

Cerebral amyloid beta protein deposits and other Alzheimer lesions in non-demented elderly east Africans.

Ogeng'o JA, Cohen DL, Sayi JG, Matuja WB, Chande HM, Kitinya JN, Kimani JK, Friedland RP, Mori H, Kalaria RN.

Brain Pathol. 1996 Apr;6(2):101-7.

PMID:
8737923
2.

Evaluation of risk factors for Alzheimer's disease in elderly east Africans.

Kalaria RN, Ogeng'o JA, Patel NB, Sayi JG, Kitinya JN, Chande HM, Matuja WB, Mtui EP, Kimani JK, Premkumar DR, Koss E, Gatere S, Friedland RP.

Brain Res Bull. 1997;44(5):573-7. Review.

PMID:
9365800
3.

Inconstant apolipoprotein E (ApoE)-like immunoreactivity in amyloid beta protein deposits: relationship with APOE genotype in aging brain and Alzheimer's disease.

Uchihara T, Duyckaerts C, Lazarini F, Mokhtari K, Seilhean D, Amouyel P, Hauw JJ.

Acta Neuropathol. 1996 Aug;92(2):180-5.

PMID:
8841664
4.

The cellular pathology associated with Alzheimer beta-amyloid deposits in non-demented aged individuals.

Coria F, Moreno A, Rubio I, GarcĂ­a MA, Morato E, Mayor F Jr.

Neuropathol Appl Neurobiol. 1993 Jun;19(3):261-8.

PMID:
8355812
5.

Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.

Snow AD, Mar H, Nochlin D, Sekiguchi RT, Kimata K, Koike Y, Wight TN.

Am J Pathol. 1990 Nov;137(5):1253-70.

6.

Neuritic pathology and dementia in Alzheimer's disease.

McKee AC, Kosik KS, Kowall NW.

Ann Neurol. 1991 Aug;30(2):156-65.

PMID:
1910274
7.

Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.

Lemere CA, Blusztajn JK, Yamaguchi H, Wisniewski T, Saido TC, Selkoe DJ.

Neurobiol Dis. 1996 Feb;3(1):16-32.

PMID:
9173910
8.
9.

Diffuse, lake-like amyloid-beta deposits in the parvopyramidal layer of the presubiculum in Alzheimer disease.

Wisniewski HM, Sadowski M, Jakubowska-Sadowska K, Tarnawski M, Wegiel J.

J Neuropathol Exp Neurol. 1998 Jul;57(7):674-83.

PMID:
9690671
10.
11.

Presence of apolipoprotein E on extracellular neurofibrillary tangles and on meningeal blood vessels precedes the Alzheimer beta-amyloid deposition.

Yamaguchi H, Ishiguro K, Sugihara S, Nakazato Y, Kawarabayashi T, Sun X, Hirai S.

Acta Neuropathol. 1994;88(5):413-9.

PMID:
7847069
12.
13.

Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury.

Ikonomovic MD, Uryu K, Abrahamson EE, Ciallella JR, Trojanowski JQ, Lee VM, Clark RS, Marion DW, Wisniewski SR, DeKosky ST.

Exp Neurol. 2004 Nov;190(1):192-203.

PMID:
15473992
14.
15.

A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated by beta protein immunostaining.

Yamaguchi H, Hirai S, Morimatsu M, Shoji M, Ihara Y.

Acta Neuropathol. 1988;76(6):541-9.

PMID:
3059748
16.

Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology.

Attems J, Lintner F, Jellinger KA.

Acta Neuropathol. 2004 Apr;107(4):283-91. Erratum in: Acta Neuropathol (Berl). 2004 May;107(5):479-80.

PMID:
14986026
17.
18.

Neuropathology of Alzheimer's disease: a critical update.

Jellinger KA, Bancher C.

J Neural Transm Suppl. 1998;54:77-95. Review.

PMID:
9850917
19.

Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.

Berg L, McKeel DW Jr, Miller JP, Storandt M, Rubin EH, Morris JC, Baty J, Coats M, Norton J, Goate AM, Price JL, Gearing M, Mirra SS, Saunders AM.

Arch Neurol. 1998 Mar;55(3):326-35.

PMID:
9520006
20.

Carboxy terminal of beta-amyloid deposits in aged human, canine, and polar bear brains.

Tekirian TL, Cole GM, Russell MJ, Yang F, Wekstein DR, Patel E, Snowdon DA, Markesbery WR, Geddes JW.

Neurobiol Aging. 1996 Mar-Apr;17(2):249-57.

PMID:
8744406

Supplemental Content

Support Center